Anumana Receives First and Only FDA Clearance for ECG-AI Cardiac Amyloidosis Algorithm Using a Standard 12-Lead ECG

Anumana and Novartis partner for AI-based heart disease detection

July 13, 2022

Anumana and Novartis partner for AI-based heart disease detection

Share
Related Articles